Jonathan Schwartz
Chief Tech/Sci/R&D Officer bij ROCKET PHARMACEUTICALS, INC.
Vermogen: 5 M $ op 31-03-2024
Oorsprong van het eerstegraads netwerk van Jonathan Schwartz
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 29 | |
| Subsidiary | Pharmaceuticals: Major | 4 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Jonathan Schwartz via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| CELGENE | Biotechnology | Corporate Officer/Principal | |
| TELIGENT | Pharmaceuticals: Major | General Counsel | |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Biotechnology | Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Human Resources Officer Chief Tech/Sci/R&D Officer | |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| VOLT INFORMATION SCIENCES, INC. | Personnel Services | Compliance Officer | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Medical Specialties | Director of Finance/CFO Investor Relations Contact | |
| BIOGEN INC. | Pharmaceuticals: Major | Director/Board Member Investor Relations Contact | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
Davidson Kempner Capital Management LP
 Davidson Kempner Capital Management LP Investment ManagersFinance Davidson Kempner Capital Management LLC (DKCM) is an independent, SEC-registered investment advisor and hedge fund management firm headquartered in New York City. The firm was founded in 1983 by Marvin Davidson and Thomas Kempner Sr. DKCM provides investment advice and investment management services to private investment funds. | Investment Managers | Corporate Officer/Principal Portfolio Manager-Equities | |
| IMUNON, INC. | Biotechnology | Corporate Officer/Principal | |
| KERYX BIOPHARMACEUTICALS | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| CYTOKINETICS, INCORPORATED | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
RTW Investments LP
 RTW Investments LP Investment ManagersFinance RTW Investments LP (RTW) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Dr. Roderick Wong in 2010. RTW provides discretionary advisory services to various RTW Funds. | Investment Managers | Chief Executive Officer Analyst-Equity | |
| AVIDITY BIOSCIENCES, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| Oracle Partners LP | Corporate Officer/Principal | ||
BDO USA PC
 BDO USA PC Miscellaneous Commercial ServicesCommercial Services BDO USA LLP operates as an accounting, auditing, and bookkeeping firm. It offers advisory; audit and assurance; digital; and tax services. The company was founded by Maximillian L. Seidman in 1910 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Karolinska Institutet | College/University | Doctorate Degree | |
| Massachusetts Institute of Technology | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Saint Joseph | College/University | Undergraduate Degree | |
| St. Joseph's University | College/University | Undergraduate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree | |
| The University of California, San Francisco | College/University | Corporate Officer/Principal | |
| The Hebrew University of Jerusalem | College/University | Doctorate Degree | |
Par Pharmaceutical, Inc.
 Par Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Par Pharmaceutical, Inc. manufactures and markets generic drugs and pharmaceuticals products. It produces drugs for hypertension, inflammation, depression and pain. The firm distributes its products in the semi-solid form of a cream. The company was founded in 1978 and is headquartered in Chestnut Ridge, NY. | Pharmaceuticals: Major | Compliance Officer | |
Veterans Administration Medical Center
 Veterans Administration Medical Center Hospital/Nursing ManagementHealth Services Veterans Administration Medical Center provides healthcare services. The private company is based in San Diego, CA. | Hospital/Nursing Management | Corporate Officer/Principal | |
Albireo Ltd.
 Albireo Ltd. Pharmaceuticals: MajorHealth Technology Albireo Ltd. develops therapies that address medical needs in the gastrointestinal and liver disease area. It is a biotechnology company that develops therapies that address unmet medical needs in the gastrointestinal area and liver disease area. The firm's programs include Cholestatic Liver Diseases; Bile Acid Mal-absorption; Type 2 Diabetes Mellitus; Atopic Dermatitis and Psoriasis; and Post-Operative Adhesions. The company was founded by Jan Peter Mattsson in February 2008 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Curate Biosciences
 Curate Biosciences Miscellaneous Commercial ServicesCommercial Services Curate Biosciences engages in the development of a liquid biopsy platform for obtaining rare circulating tumor cells. It offers a desktop fluidic system for cell separation that pumps blood through a disposable microchip. The company was founded by Michael D. Grisham in 2002 and is headquartered in Richmond, VA. | Miscellaneous Commercial Services | Director/Board Member | |
| IMMUNE PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
Uppsala University Hospital
 Uppsala University Hospital Hospital/Nursing ManagementHealth Services Uppsala University Hospital operates a hospital. | Hospital/Nursing Management | Corporate Officer/Principal | |
| TRAVERE THERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Perelman School of Medicine | College/University | Doctorate Degree Graduate Degree | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| The Leonard N Stern School of Business | College/University | Masters Business Admin Masters Business Admin | |
| Fu Foundation School of Engineering & Applied Science | College/University | Graduate Degree | |
Rocket Pharmaceuticals Ltd.
 Rocket Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Rocket Pharmaceuticals Ltd. operates as a biotechnology company which focuses on developing gene therapy treatment for undertreated diseases. The firm’s pipeline includes Fanconi Anemia, Pyruvate Kinase Deficiency, Leukocyte Adhesion Deficiency-1 and Infantile Malignant Osteopetrosis. It also develops an AAV-based therapy program for an undisclosed rare pediatric disease. The company is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member Chairman Chief Executive Officer Chief Operating Officer | |
| TSCAN THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Director/Board Member | |
RTW Investments /Venture/
 RTW Investments /Venture/ Investment ManagersFinance RTW Investments /Venture/ (RTW Investments) is a venture capital subsidiary of RTW Investments LP founded in 2009 by Roderick Wong. The firm is headquartered in New York. | Investment Managers | Chief Investment Officer Private Equity Investor Private Equity Investor | |
Ichnos Sciences, Inc.
 Ichnos Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Ichnos Sciences, Inc. operates as a biotechnology company. It provides curative therapies that extend human life. The company was founded in 2019 and is headquartered in Paramus, NJ. | Miscellaneous Commercial Services | Corporate Officer/Principal Human Resources Officer | |
| Life Sciences Practice Group | Corporate Officer/Principal | ||
Andelyn Biosciences
 Andelyn Biosciences BiotechnologyHealth Technology Andelyn Biosciences is a full-service cell and gene therapy company that specializes in the development, characterization, and production of viral vectors for gene therapy. The private company is based in Columbus, OH. The company operates out of three facilities in Ohio and offers support to its clients in developing curative cell and gene therapies from concept through plasmid development and manufacturing, process development, and cgmp clinical and commercial manufacturing. Andelyn's advanced digital model, quality system, full regulatory support, and supply chain vertical integration help accelerate the development and manufacturing of its clients' innovative cell and gene therapies. The company has more than 20 years of experience and has produced cgmp material for over 450 clinical batches and 75 clinical trials. Andelyn's versatile capabilities include cgmp manufacturing capacity for both adherent and suspension processes up to a 2,000-liter capacity. The CEO of the company is Wade Macedone. | Biotechnology | Chief Executive Officer | |
| NUVECTIS PHARMA, INC. | Pharmaceuticals: Major | Founder Founder |
Statistieken
Internationaal
| Verenigde Staten | 45 |
| Verenigd Koninkrijk | 3 |
| Zweden | 3 |
| Israël | 2 |
Sectoraal
| Health Technology | 25 |
| Consumer Services | 11 |
| Finance | 8 |
| Commercial Services | 5 |
| Health Services | 3 |
Operationeel
| Director/Board Member | 89 |
| Corporate Officer/Principal | 75 |
| Independent Dir/Board Member | 33 |
| Undergraduate Degree | 25 |
| Chief Tech/Sci/R&D Officer | 18 |
Sterkste connecties
| Insiders | |
|---|---|
| Eric Rowinsky | 36 |
| David Southwell | 19 |
| Pedro Granadillo | 16 |
| Carsten Boess | 15 |
| Rod Wong | 15 |
| Naveen Yalamanchi | 15 |
| Claudine Prowse | 12 |
| Margareta Elisabeth Björk | 12 |
| Alan Forman | 11 |
| Gregory MacMichael | 11 |
| Mayo Pujols | 11 |
| Gotham Makker | 9 |
| Martin Wilson | 9 |
| R. Woods | 8 |
| Gaurav D. Shah | 8 |
- Beurs
- Insiders
- Jonathan Schwartz
- Bedrijfsconnecties
